Tandem Diabetes Care Inc (NAS:TNDM)
$ 37.37 0.37 (1%) Market Cap: 2.45 Bil Enterprise Value: 2.43 Bil PE Ratio: 0 PB Ratio: 10.32 GF Score: 80/100

Tandem Diabetes Care Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2023 / 05:30PM GMT
Release Date Price: $24.18 (-2.54%)
Matthew Charles Taylor
Jefferies LLC, Research Division - Equity Analyst

Okay. We're ready to get started here with our next session. I'm really pleased to be joined by the management team from Tandem. And I'm Matt Taylor, the U.S. medical supplies and devices analyst here at Jefferies. I just want to introduce the team. John Sheridan is the President and CEO; and Leigh Vosseller is the CFO. So we're meant to have about a 25-minute Q&A session that I'll drive via a fireside chat, and then maybe we'll have a couple of minutes at the end if the audience has any questions.

Questions & Answers

Matthew Charles Taylor
Jefferies LLC, Research Division - Equity Analyst

So I'll give you my first question here from the podium and then joining there in the green room. But I always like to start high level. So maybe stepping back, talking about the insulin pump market. It's been growing nicely in the past few years and really driven by a lot of advances in the technology, not only of the pumps, but of the enabling tech, whether it's CGMs or software. But I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot